Clinical Trial

Vivifi's Treatment, BPH Treatment Via Vasculature Anastomosis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 11, 2025 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The study objective is to evaluate the safety and feasibility of the Vivifi's Treatment. The Vivifi's Treatment presents an innovative approach for addressing benign prostatic hyperplasia (BPH) as well as clinical/subclinical varicoceles in men. The scientific rationale for conducting this study is to assess the safety and feasibility of the Vivifi's Treatment (a surgical procedure) as a therapeutic intervention for patients with BPH.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-05-16; most recent amendment 2025-04-08.
Status change: Not Yet Recruiting → Recruiting 2025-04-08
Trial Details
NCT Number NCT06424912
Lead Sponsor Vivifi Medical
Collaborators: RQM+
Conditions Benign Prostatic Hyperplasia, Varicocele Grade II, Varicocele Grade III
Enrollment 20 participants
Start Date 2024-11-13
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-11